Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Watch and Learn: Gaining Insight on Parkinson's Using Wearable Technology

    Watch and Learn: Gaining Insight on Parkinson's Using Wearable Technology

    MJFF partnered with Intel to gather, measure and evaluate PD symptoms using "smart" wearable technology worn by people with PD. The first dataset will be available to researchers this…
    Learn more
  • New Study Reveals Potential Biomarkers for Cognitive Changes in Early Parkinson's

    New Study Reveals Potential Biomarkers for Cognitive Changes in Early Parkinson's

    Analysis of data from the MJFF-sponsored Parkinson's Progression Markers Initiative gives window into how and why cognitive problems develop in PD
    Learn more
  • Palfreman: Toward Parkinson's Personalized Medicine

    Palfreman: Toward Parkinson's Personalized Medicine

    In his latest blog post for the Journal of Parkinson's Disease, science journalist and person with Parkinson's Jon Palfreman introduces us to Personalized Parkinson Project.
    Learn more
  • Research Recap: Highlights from the American Academy of Neurology Meeting

    Research Recap: Highlights from the American Academy of Neurology Meeting

    Researchers met to discuss the latest news in neurology and PD at the American Academy of Neurology meeting. Presenters shared results from trials of potential treatments.
    Learn more
  • Tracing the Origins of Parkinson's to the Gut

    Tracing the Origins of Parkinson's to the Gut

    A new study builds on the theory that PD could start in the gut, rather than the brain.
    Learn more
  • New Data on Extended-Release Amantadine for Dyskinesia

    New Data on Extended-Release Amantadine for Dyskinesia

    This week, Adamas Pharmaceuticals announced new data for a dyskinesia drug -- an extended-release formulation of amantadine designed to be taken once daily at bedtime.
    Learn more
  • Study Reveals Risk Factors for Early Psychosis in Parkinson's

    Study Reveals Risk Factors for Early Psychosis in Parkinson's

    A recent study using data from PPMI has identified risk factors that may predict the development of early psychosis in Parkinson's.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.
Here. Until Parkinson's isn't.
Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's.
 
 
 
 
Month
Day
Year